Clinuvel Pharmaceuticals Limited (ASX: CUV) Share Price and News
Chart and Price Data
|Avg Daily Volume|
|52 Week Range||-|
|Year Return (Capital)|
Clinuvel Pharmaceuticals Limited (CUV) is a global biopharmaceutical company that develops drugs for the treatment of a range of skin disorders. The company’s flagship product is Scenesse, a drug designed for the treatment of erythropoietic protoporphyria (EPP). EPP is a rare metabolic disorder which causes burns after brief exposure to visible light, especially sunlight. It is estimated that there are 5,000 to 10,000 EPP patients worldwide.
Clinuvel is also seeking to progress the use of Scenesse for the treatment of vitiligo, a skin disorder characterised by the appearance of white to off-white skin patches due to the loss of melanin production.
The company’s history dates back to 1987 when university researchers devised an idea of synthesising human hormones to protect the skin. Clinuvel shares have been listed on the ASX since 2001 and as a biopharmaceutical company, the Clinuvel share price can often be particularly volatile, bouncing around in response to announcements such as clinical trials and new launches.
Clinuvel Pharmaceuticals Limited (ASX: CUV) Latest News
James Mickleboro | July 15, 2020 12:08pm
Afterpay Ltd (ASX:APT) and Westpac Banking Corp (ASX:WBC) shares are making a splash on the ASX 200 on Wednesday. Here's why... More »
James Mickleboro | July 4, 2020 9:34am
Here's what would have happened if you invested $20,000 into CSL Limited (ASX:CSL) and these ASX shares 10 years ago... More »
Kate O'Brien | June 22, 2020 11:14am
The S&P/ASX 200 Index (ASX: XJO) gained 1.6% last week, returning to its recent strong form. Here are the 5 ASX shares that saw... More »
James Mickleboro | June 20, 2020 9:19am
Healius Ltd (ASX:HLS) and Appen Ltd (ASX:APX) shares were among the best performers on the ASX 200 last week. Here's why they jumped... More »
Tristan Harrison | June 17, 2020 6:00pm
The S&P/ASX 200 Index (ASX:XJO) climbed higher by 0.8% today. One highlight was Carsales.com Ltd (ASX:CAR) revealing what it expects in FY20. More »
Will Clinuvel Pharmaceuticals pay a dividend in 2020?
Clinuvel Pharmaceuticals listed on the ASX in 2001 and only recently declared a profit for the first time in FY2017. Since then, the company went on to achieve increased profits across both FY2018 and FY2019. It also distributed final dividends of 2 cents and 2.5 cents per share for FY2018 and FY2019 respectively. As at 17 June 2020, Clinuvel has made no announcements regarding the status of its FY2020 dividend payment.
Does Clinuvel Pharmaceuticals offer a DRP?
Having only started paying dividends over the last couple of years, Clinuvel Pharmaceuticals does not currently offer a dividend reinvestment plan.